SecSonar.com

PROCEPT BioRobotics Corporation (PRCT)

PROCEPT BioRobotics Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

PROCEPT BioRobotics Corporation (PRCT) is a Medical - Devices company based in US with a market capitalization of $1.5B. Revenue grew 37.2% year-over-year and free cash flow was negative at -$58.3M. This page tracks PRCT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 756 employees · IPO Sep 15, 2021

Valuation

Valuation & price

$26.12 · as of May 17, 2026 · -56.5% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

4.21

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$60.06$40.45$20.85Jul 25Dec 25Jul 26Jul 7, 25$56.97Jul 9, 25$58.46Jul 11, 25$56.65Jul 15, 25$58.01Jul 17, 25$58.93Jul 21, 25$57.05Jul 23, 25$60.06Jul 25, 25$55.72Jul 29, 25$53.84Jul 31, 25$48.51Aug 4, 25$49.60Aug 6, 25$45.69Aug 11, 25$38.77Aug 13, 25$40.38Aug 15, 25$41.59Aug 19, 25$39.72Aug 21, 25$39.35Aug 25, 25$39.31Aug 27, 25$40.80Aug 29, 25$40.17Sep 3, 25$37.84Sep 5, 25$40.68Sep 9, 25$39.52Sep 11, 25$38.64Sep 16, 25$39.57Sep 18, 25$38.03Sep 22, 25$38.46Sep 24, 25$37.65Sep 26, 25$36.66Sep 30, 25$35.69Oct 2, 25$34.80Oct 6, 25$35.24Oct 8, 25$34.75Oct 10, 25$32.92Oct 14, 25$33.92Oct 16, 25$33.94Oct 21, 25$34.61Oct 23, 25$34.62Oct 27, 25$36.35Oct 29, 25$35.93Oct 31, 25$34.03Nov 4, 25$35.02Nov 6, 25$31.30Nov 10, 25$30.94Nov 12, 25$30.77Nov 14, 25$29.69Nov 18, 25$28.40Nov 20, 25$27.89Nov 25, 25$32.27Nov 28, 25$31.68Dec 2, 25$29.53Dec 4, 25$35.43Dec 8, 25$34.03Dec 10, 25$35.71Dec 12, 25$35.99Dec 16, 25$35.66Dec 18, 25$32.73Dec 22, 25$34.26Dec 24, 25$32.88Dec 29, 25$32.15Jan 2, 26$30.76Jan 6, 26$34.71Jan 8, 26$34.48Jan 12, 26$31.33Jan 14, 26$31.37Jan 16, 26$30.38Jan 21, 26$30.95Jan 23, 26$29.13Jan 27, 26$30.78Jan 29, 26$29.12Feb 2, 26$29.14Feb 4, 26$28.93Feb 9, 26$29.21Feb 11, 26$28.50Feb 13, 26$27.79Feb 18, 26$27.72Feb 20, 26$27.27Feb 24, 26$27.26Feb 26, 26$23.63Mar 2, 26$25.90Mar 4, 26$26.56Mar 6, 26$24.22Mar 10, 26$24.17Mar 12, 26$26.12Mar 17, 26$27.36Mar 19, 26$25.68Mar 23, 26$26.02Mar 25, 26$24.94Mar 27, 26$26.36Mar 31, 26$25.01Apr 2, 26$25.12Apr 7, 26$23.19Apr 9, 26$23.27Apr 13, 26$23.46Apr 15, 26$25.67Apr 17, 26$25.14Apr 22, 26$25.11Apr 24, 26$24.36Apr 28, 26$23.03Apr 30, 26$24.04May 4, 26$24.83May 6, 26$24.80May 8, 26$25.40May 12, 26$28.69May 14, 26$26.38May 18, 26$26.01May 20, 26$28.11May 22, 26$29.00May 28, 26$27.20Jun 1, 26$27.86Jun 3, 26$26.33Jun 5, 26$27.83Jun 9, 26$28.78Jun 11, 26$27.69Jun 15, 26$23.22Jun 17, 26$20.91Jun 22, 26$21.06Jun 24, 26$20.85Jun 26, 26$22.56Jul 2, 26$21.03
$20.6052-week range$60.06
Loading valuation history…

Fundamentals

Key fundamentals

$1.5B

Market cap

37.2%

Revenue growth (YoY)

63.7%

Gross margin

-$58.3M

Free cash flow (USD)

-$234.9M

Net debt

Net cash position

6.6%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$6.2MFY 2020$7.7MFY 2021$34.5MFY 2022$75.0MFY 2023$136.2MFY 2024$224.5MFY 2025$308.1M
$6.2M$308.1M

Free cash flow by year

2019 → 2025

FY 2019$-51.4MFY 2020$-48.6MFY 2021$-57.9MFY 2022$-83.0MFY 2023$-133.2MFY 2024$-103.6MFY 2025$-58.3M
-$51.4M-$58.3M

Gross margin by year

2021 → 2025

FY 202146.0%FY 202249.4%FY 202352.2%FY 202461.1%FY 202563.7%
46.0%63.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

3

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 30, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $10KTemplin Barry L · EVP, Chief Technology Officer · $10.2KJun 10, 2026Filing
  • Insider sellInsider Sell $10KWaters Kevin · EVP, CFO · $10.2KJun 10, 2026Filing
  • Insider sellInsider Sell $8KNouri Alaleh · EVP, CLO, CORP. SEC. · $8.1KJun 10, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 10, 2026Filing
  • Quarterly report10-Q FiledApr 30, 2026Filing
  • 8-K eventEarnings ReleaseApr 29, 2026Filing

Questions

Frequently asked questions

What is PROCEPT BioRobotics Corporation's market cap?

PROCEPT BioRobotics Corporation (PRCT) has a market capitalization of $1.5B.

What is PRCT's P/E ratio?

A meaningful P/E ratio is not available for PRCT — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is PRCT's price-to-book (P/B) ratio?

PRCT trades at 4.21 times book value per share.

Are insiders buying PRCT stock?

SEC Form 4 filings show no open-market insider buys at PROCEPT BioRobotics Corporation in the last 90 days (3 sells).

Same arena

Related companies in Medical - Devices

AHCO

AdaptHealth Corp.

$1.4B

UFPT

UFP Technologies, Inc.

$1.7B

ENOV

Enovis Corporation

$1.3B

IART

Integra LifeSciences Holdings Corporation

$1.3B

INSP

Inspire Medical Systems, Inc.

$1.2B

ATEC

Alphatec Holdings, Inc.

$1.2B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.